These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4606971)

  • 1. Purified Vi antigens as possible typhoid vaccines.
    Pistole TG; Marcus S
    Immunol Commun; 1974; 3(3):227-38. PubMed ID: 4606971
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemically-modified crude endotoxins as possible typhoid vaccines.
    Pistole TG; Marcus S
    Immunol Commun; 1973; 2(1):43-56. PubMed ID: 4609894
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of purified Vi polysaccharide typhoid vaccine.
    Park JH; Hong JJ; Choi ES; Lee JW; Park JH
    J Vet Sci; 2002 Jun; 3(2):67-70. PubMed ID: 12441674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The characteristics of an antigenic preparation from Salmonella typhi Ty(2)4446 isolated using hydroxylamine hydrochloride].
    Sergeev VV; Tsvetkova NV; Iastrebova NE; Kaverina KG; Ian'kova MM; Sokolova TV
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):65. PubMed ID: 8079573
    [No Abstract]   [Full Text] [Related]  

  • 5. Ineffectiveness of Vi and chemically treated endotoxins as typhoid vaccines in mice challenged with a Salmonella typhosa-Salmonella typhimurium hybrid.
    Diena BB; Ryan A; Wallace R; Ashton FE; Johnson EM; Baron LS
    Infect Immun; 1975 Dec; 12(6):1470-1. PubMed ID: 1107227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vi antigen from Salmonella typhosa and immunity against typhoid fever. I. Isolation and immunologic properties in animals.
    Wong KH; Feeley JC; Northrup RS; Forlines ME
    Infect Immun; 1974 Feb; 9(2):348-53. PubMed ID: 4205947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Production of a complex chemical typhoid vaccine containing O-, Vi, and H-antigens].
    Gekker VD; Sergeeva NS
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Jan; 50(1):14-8. PubMed ID: 4780106
    [No Abstract]   [Full Text] [Related]  

  • 8. [Live enteric typhoid vaccine consisting of a Vi-negative double-dependent mutant of S. typhi and a Vi-positive strain of Citrobacter].
    Pershin BB; Shuster BIu; Maganet LS; Tolcheev IuD
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Jan; (1):35-40. PubMed ID: 60853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adhesion of Vi antigen and toxicity in typhoid vaccines inactivated by acetone or by heat and phenol.
    Wong KH; Feeley JC; Pittman M; Forlines ME
    J Infect Dis; 1974 May; 129(5):501-6. PubMed ID: 4207306
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of DDT on antibody response to typhoid vaccine in rabbits and man.
    Shiplov J; Graber CD; Keil JE; Sandifer SH
    Immunol Commun; 1972; 1(4):385-94. PubMed ID: 4680354
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparison of oral and subcutaneous immunization against typhoid-paratyphoid fever (author's transl)].
    Krasnoproshina LI
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):151-60. PubMed ID: 4216249
    [No Abstract]   [Full Text] [Related]  

  • 12. [Problems of the immunomechanism by oral typhus immunization].
    Jandl G
    Zentralbl Bakteriol Orig; 1965 Dec; 198(1):179-81. PubMed ID: 5336930
    [No Abstract]   [Full Text] [Related]  

  • 13. [Molecular heterogeneity of preparations of typhoid-paratyphoid group bacterial endotoxins. IV. The effect of the molecular parameters of the antigenic fractions on the formation of individual classes of immunoglobulins].
    Shapiro NI; Repina GV
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jun; 51(6):40-6. PubMed ID: 4410169
    [No Abstract]   [Full Text] [Related]  

  • 14. [Characteristics of preparations of typhoid antigens obtained by ultrafiltration].
    Khokholev LS; Shapiro NI; Katalevskiĭ EE
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Jan; (1):81-4. PubMed ID: 7234247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Factors affecting potency during the production of typhoid vaccine].
    Porras Lanzagorta M; Montesinos FN; González Pacheco M
    Salud Publica Mex; 1981; 23(6):633-40. PubMed ID: 7038910
    [No Abstract]   [Full Text] [Related]  

  • 16. [Stable expression and immunogenicity in a attenuated Salmonella typhi strain of coli surface antigen-6 of enterotoxigenic Escherichia coli].
    Teng J; Rui X; Zhang Y; Zhang Z; Su G
    Wei Sheng Wu Xue Bao; 1999 Dec; 39(6):533-8. PubMed ID: 12555559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi.
    Robbins JD; Robbins JB
    J Infect Dis; 1984 Sep; 150(3):436-49. PubMed ID: 6207249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular heterogeneity of preparations of endotoxins of bacteria of the typhoid-paratyphoid group. II. Antigenic structure and biological activity of high and low molecular fractions].
    Shapiro NI; Vasil'eva TG; Moskvicheva IV; Dudkina MI; Kruglikhina ZM
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Nov; 48(11):35-9. PubMed ID: 5135464
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunochemical study of the antigenic complexes from typhoid-paratyphoid A and B bacteria obtained industrially].
    Khatuntseva NV; Mironova MV; Riapolova RG; Rybasova GV
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jun; 51(6):50-5. PubMed ID: 4409774
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of a Vi-degrading enzyme on potency of typhoid vaccines in mice.
    Wong KH; Feeley JC; Pittman M
    J Infect Dis; 1972 Apr; 125(4):360-6. PubMed ID: 4553079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.